The most commonly reported side effects of sodium chromate cr-51 include gastrointestinal haemorrhage, blood glucose decreased, and chest pain, based on 6 FDA adverse event reports from 2005 to 2021.
Percentages show how often each reaction appears relative to total reports for sodium chromate cr-51.
These are voluntary reports and do not establish that sodium chromate cr-51 caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside sodium chromate cr-51. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Taken alongside
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
33.3% of sodium chromate cr-51 adverse event reports involve female patients and 66.7% involve male patients. The largest age group is elderly at 67%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking sodium chromate cr-51 when the adverse event was reported.
Sodium Chromate Cr-51 is sold under the brand name Chromitope Sodium.
An upward trend reflects increased FAERS reporting overall, not necessarily increased risk.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.